BCM
Boone Capital Management Portfolio holdings
AUM
$233M
This Quarter Return
+29.78%
1 Year Return
+15.17%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$195M
AUM Growth
–
Cap. Flow
+$195M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
80.45%
Holding
17
New
17
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Unum
UNM
|
$27.6M |
| 2 |
Cigna
CI
|
$19.6M |
| 3 |
Eli Lilly
LLY
|
$17.4M |
| 4 |
Enovis
ENOV
|
$14.8M |
| 5 |
Danaher
DHR
|
$14.4M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 85.17% |
| 2 | Financials | 14.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Unum
UNM
$11.9B
| $27.6M | 14.14% |
+671,530
| New | +$27.6M |
|
|
2
Cigna
CI
$80.3B
| $19.6M | 10.04% |
+59,029
| New | +$19.6M |
|
|
3
Eli Lilly
LLY
$657B
| $17.4M | 8.91% |
+47,448
| New | +$17.4M |
|
|
4
Enovis
ENOV
$1.77B
| $14.8M | 7.59% |
+276,246
| New | +$14.8M |
|
|
5
Danaher
DHR
$147B
| $14.4M | 7.4% |
+54,356
| New | +$14.4M |
|
6
Organon & Co
OGN
$2.45B
| $13.9M | 7.14% |
+498,262
| New | +$13.9M |
|
7
Molina Healthcare
MOH
$9.8B
| $13M | 6.68% |
+39,444
| New | +$13M |
|
8
Abbott
ABT
$231B
| $12.3M | 6.32% |
+112,106
| New | +$12.3M |
|
9
AbbVie
ABBV
$372B
| $12.3M | 6.29% |
+75,873
| New | +$12.3M |
|
10
Biogen
BIIB
$19.4B
| $11.6M | 5.95% |
+41,843
| New | +$11.6M |
|
|
MDRX
11
DELISTED
Veradigm Inc. Common Stock
MDRX
| $10.6M | 5.43% |
+600,000
| New | +$10.6M |
|
|
APEN
12
DELISTED
Apollo Endosurgery, Inc.
APEN
| $7.16M | 3.68% |
+718,419
| New | +$7.16M |
|
13
Quanterix
QTRX
$211M
| $6.79M | 3.48% |
+490,225
| New | +$6.79M |
|
14
TruBridge
TBRG
$300M
| $6.19M | 3.18% |
+227,365
| New | +$6.19M |
|
|
AFMD
15
DELISTED
Affimed
AFMD
| $3.56M | 1.83% |
+2,869,744
| New | +$3.56M |
|
16
Cabaletta Bio
CABA
$133M
| $2.47M | 1.27% |
+266,882
| New | +$2.47M |
|
|
CSII
17
DELISTED
Cardiovascular Systems, Inc.
CSII
| $1.35M | 0.69% |
+99,157
| New | +$1.35M |
|